المؤلفون: Jinping YUAN, Jiaying LIN, Bingxue BAI

المصدر: Pifu-xingbing zhenliaoxue zazhi, Vol 30, Iss 5, Pp 412-416 (2023)

مصطلحات موضوعية: atopic dermatitis, clinical features, disease disturbance, therapeutic goals, Dermatology, RL1-803

وصف الملف: electronic resource

العلاقة: http://pfxbzlx.gdvdc.com/EN/10.3969/j.issn.1674-8468.2023.05.003Test; https://doaj.org/toc/1674-8468Test

الوصول الحر: https://doaj.org/article/3dd08bb476434292a9cc3c38c1bb2b9cTest

المؤلفون: O. V. Svetlova, I. V. Gurieva, D. V. Kuzina, A. V. Voronin, О. В. Светлова, И. В. Гурьева, И. В. Кузина, А. В. Воронин

المصدر: Meditsinskiy sovet = Medical Council; № 23 (2023); 192-200 ; Медицинский Совет; № 23 (2023); 192-200 ; 2658-5790 ; 2079-701X

مصطلحات موضوعية: инсулинорезистентность, therapeutic goals, metformin, glycemic control, insulin resistance, терапевтические цели, метформин, контроль гликемии

وصف الملف: application/pdf

العلاقة: https://www.med-sovet.pro/jour/article/view/8018/7110Test; Дедов ИИ, Шестакова МВ, Майоров АЮ. (ред.). Алгоритмы специализированной медицинской помощи больным сахарным диабетом. М.; 2023. 234 с. Режим доступа: https://webmed.irkutsk.ru/doc/pdf/algosd.pdfTest.; Дедов ИИ, Шестакова МВ, Галстян ГР. Распространенность сахарного диабета 2-го типа у взрослого населения России (исследование NATION). Сахарный диабет. 2016;19(2):104–112. https://doi.org/10.14341/DM2004116-17Test.; Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000;321(7258):405–412. https://doi.org/10.1136/bmj.321.7258.405Test.; Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998;352(9131):854–865. Available at: https://pubmed.ncbi.nlm.nih.gov/9742977Test.; Бирюкова ЕВ, Шинкин МВ, Соловьева ИВ. Современная практика самоконтроля гликемии: основы эффективного управления сахарным диабетом. Клинический разбор в общей медицине. 2023;4(2):60–67 https://doi.org/10.47407/kr2023.4.2.00205Test.; Светлова ОВ, Гурьева ИВ. Инновационные технологии в управлении сахарным диабетом: предупреждение гипогликемии. Медицинский совет. 2023;17(9):89–95. https://doi.org/10.21518/ms2023-167Test.; Светлова ОВ, Гурьева ИВ, Савченко ЛС. Современные возможности самоконтроля: Новая эра эффективного управления сахарным диабетом. Медицинский совет. 2019;(4):30–33. https://doi.org/10.21518/2079701X-2019-4-30-33Test.; Моргунова ТБ, Глинкина ИВ, Пешева ЕД, Зорина АА, Фадеев ВВ. Место метформина в современных клинических рекомендациях по лечению сахарного диабета 2-го типа. Медицинский совет. 2023;17(13):122–129. https://doi.org/10.21518/ms2023-211Test.; Моргунов ЛЮ. Сиофор: плейотропные эффекты в реальной клинической практике. Эффективная фармакотерапия. Эндокринология. 2014;(5):46. Режим доступа: https://umedp.ru/articles/siofor_pleyotropnye_effekty_v_realnoy_klinicheskoy_praktike.html?forgot_password=yes&%2Farticles%2Fsiofor_pleyotropnye_effekty_v_realnoy_klinicheskoy_praktike_htmlTest.; Sanchez-Rangel E, Inzucchi SE. Metformin: clinical use in type 2 diabetes. Diabetologia. 2017;60(9):1586–1593. https://doi.org/10.1007/s00125-017-336-xTest.; Introduction: Standards of Medical Care in Diabetes-2018. Diabetes Care. 2018;41(1):1–2. https://doi.org/10.2337/dc18-Sint01Test.; Bonnet F, Scheen A. Understanding and overcoming metformin gastrointestinal intolerance. Diabetes Obes Metab. 2017;19(4):473–481. https://doi.org/10.1111/dom.12854Test.; Bailey CJ, Day C. Traditional plant medicines as treatments for diabetes. Diabetes Care. 1989;12(8):553–564. https://doi.org/10.2337/diacare.12.8.553Test.; Sivitz WI, Phillips LS, Wexler DJ, Fortmann SP, Camp AW, Tiktin M. et al. Optimization of Metformin in the GRADE Cohort: Effect on Glycemia and Body Weight. Diabetes Care. 2020;43(5):940–947. https://doi.org/10.2337/dc19-1769Test.; Walker EA, Gonzalez JS, Tripputi MT, Dagogo-Jack S, Matulik MJ, Montez MG et al. Group. Long-term metformin adherence in the Diabetes Prevention Program Outcomes Study. BMJ Open Diabetes Res Care. 2020;8(1):e001537. https://doi.org/10.1136/bmjdrc-2020-001537Test.; Garber AJ, Handelsman Y, Grunberger G, Einhorn D, Abrahamson MJ, Barzilay JI et al. Consensus statement by the American association of clinical endocrinologists and American college of endocrinology on the comprehensive type 2 diabetes management algorithm – 2020. Endocr Pract. 2020;26(1):107–139. https://doi.org/10.4158/CS-2019-0472Test.; Patel-Sanchez N, Perito E, Tsai P, Raymond-Flesch M, Lodish M, Sarkar M. Prevalence of nonalcoholic fatty liver disease increased with type 2 diabetes mellitus in overweight/obese youth with polycystic ovary syndrome. J Pediatr Endocrinol Metab. 2023;36(5):441–446. https://doi.org/10.1515/jpem-2022-0527Test.; Stedman M, Rea R, Duff CJ, Livingston M, McLoughlin K, Wong L et al. People with Type Diabetes Mellitus (T1DM) self-reported views on their own condition management reveal links to potentially improved outcomes and potential areas for service improvement. Diabetes Res Clin Pract. 2020;170:108479. https://doi.org/10.1016/j.diabres.2020.108479Test.; Дедов ИИ, Шестакова МВ, Викулова ОК, Железнякова АВ, Исаков МА. Эпидемиологические характеристики сахарного диабета в Российской Федерации: клинико-статистический анализ по данным регистра сахарного диабета на 01.01.2021. Сахарный диабет. 2021;24(3):204–221. https://doi.org/10.14341/DM12759Test.; Kautzky-Willer A, Michael Leutner M, Jürgen Harreiter J. Sex differences in type 2 diabetes. Diabetologia. 2023;66(6):986–1002. https://doi.org/10.1007/s00125-023-05891-xTest.; Hong SH, Sung YA, Hong YS, Song DK, Jung H, Jeong K et al. Non-alcoholic fatty liver disease is associated with hyperandrogenism in women with polycystic ovary syndrome. Sci Rep. 2023;13(1):13397. https://doi.org/10.1038/s41598-023-39428-4Test.; Abu-Freha N, Cohen B, Weissmann S, Hizkiya R, Abu-Hammad R, Gadeer Taha G, Gordon M. Comorbidities and Outcomes among Females with Non-Alcoholic Fatty Liver Disease Compared to Males. Biomedicines. 2022;10(11):2908. https://doi.org/10.3390/biomedicines10112908Test.; Chang SH, Wu LS, Chiou MJ, Liu JR, Yu KH, Kuo CF et al. Association of metformin with lower atrial fibrillation risk among patients with type 2 diabetes mellitus: a population-based dynamic cohort and in vitro studies. Cardiovasc Diabetol. 2014;13:123. https://doi.org/10.1186/s12933-014-0123-xTest.; DiStefano JK. The Role of Choline, Soy Isoflavones, and Probiotics as Adjuvant Treatments in the Prevention and Management of NAFLD in Postmenopausal Women. Nutrients. 2023;15(12):2670. https://doi.org/10.3390/nu15122670Test.; Соколова АВ, Климова АВ, Драгунов ДО, Арутюнов ГП. Оценка влияния терапии метформином на величину мышечной массы и мышечной силы у больных с и без сахарного диабета. Метаанализ 15 исследований. Российский кардиологический журнал. 2021;26(3):4331. https://doi.org/10.15829/1560-4071-2021-4331Test.; Григорьева ИИ, Раскина ТА, Летаева МВ, Малышенко ОС, Аверкиева ЮВ, Масенко ВЛ, Коков АН. Саркопения: особенности патогенеза и диагностики. Фундаментальная и клиническая медицина. 2019;4(4):105–116. https://doi.org/10.23946/2500-0764-2019-4-4-105-116Test.; Rodriguez Moctezuma JR, Robles López G, López Carmona JM, Gutiérrez- Rosas MJ. Effects of metformin on the body composition in subjects with risk factors for type 2 diabetes. Diabetes Obes Metab. 2005;7(2):189–192. https://doi.org/10.1111/j.1463-1326.2004.00385.xTest.; Chen LK, Woo J, Assantachai P, Auyeung TW, Chou MY, Iijima K et al. Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment. J Am Med Dir Assoc. 2020;21(3):300–307. https://doi.org/10.1016/j.jamda.2019.12.012Test.; Matthews DR, Paldánius PM, Proot P, Chiang Y, Stumvoll M, Del Prato S. Glycaemic durability of an early combination therapy with vildagliptin and metformin versus sequential metformin monotherapy in newly diagnosed type 2 diabetes (VERIFY): a 5-year, multicentre, randomised, double-blind trial. Lancet. 2019;394(10208):1519–1529. https://doi.org/10.1016/s0140-6736Test(19)32131-2.; Wee AKH, Sultana R. Determinants of vitamin B12 deficiency in patients with type-2 diabetes mellitus – A primary-care retrospective cohort study. BMC Prim Care. 2023;24(1):102. https://doi.org/10.1186/s12875-023-02057-xTest.; Schwartz S, Fonseca V, Berner B, Cramer M, Chiang YK, Lewin A. Efficacy, tolerability, and safety of a novel once-daily extended-release metformin in patients with type 2 diabetes. Diabetes Care. 2006;29(4):759–764. https://doi.org/10.2337/diacare.29.04.06.dc05-1967Test.; Rathis TS, Ranganathan RS, Solai Raja M, Srivastav PSS. Prevalence of Vitamin B12 Deficiency in Type 2 Diabetes Mellitus Patients on Metformin Therapy. Cureus. 2023;15(4):e37466. https://doi.org/10.7759/Cureus.37466Test.; Kim J, Ahn CW, Fang S, Lee HS, Park JS. Association between metformin dose and vitamin B12 deficiency in patients with type 2 diabetes. Medicine (Baltimore). 2019;98(46):e17918. https://doi.org/10.1097MD.0000000000017918Test.; https://www.med-sovet.pro/jour/article/view/8018Test

الإتاحة: https://doi.org/10.21518/ms2023-466Test
https://doi.org/10.14341/DM2004116-17Test
https://doi.org/10.1136/bmj.321.7258.405Test
https://doi.org/10.47407/kr2023.4.2.00205Test
https://doi.org/10.21518/ms2023-167Test
https://doi.org/10.21518/2079701X-2019-4-30-33Test
https://doi.org/10.21518/ms2023-211Test
https://doi.org/10.1007/s00125-017-336-xTest
https://doi.org/10.2337/dc18-Sint01Test
https://doi.org/10.1111/dom.12854Test

المؤلفون: Antonio Vita, Andrea Fagiolini, Giuseppe Maina, Claudio Mencacci, Edoardo Spina, Silvana Galderisi

المصدر: Annals of General Psychiatry, Vol 22, Iss 1, Pp 1-8 (2023)

مصطلحات موضوعية: Schizophrenia, Long-acting injectable, Risperidone ISM®, Therapeutic goals, Psychiatry, RC435-571

وصف الملف: electronic resource

العلاقة: https://doaj.org/toc/1744-859XTest

الوصول الحر: https://doaj.org/article/caf4071126744394b03c314c1e2f1a66Test

المؤلفون: Heuvel,van den, Renée, Lid lectoraat, Lexis, Monique, Lid lectoraat, Witte,de, Luc, Lector

المساهمون: Lectoraat Ondersteunende Technologie in de Zorg, Zuyd Hogeschool@@@Faculteit Gezondheidszorg

المصدر: International Journal of Social Robotics. 12

مصطلحات موضوعية: effects, roles, children, physical disabilities, educational goals, therapeutic goals, robots

الوصول الحر: https://surfsharekit.nl/public/5f1c0f89-f5d1-4d47-bbe1-13b117f453edTest
https://surfsharekit.nl/objectstore/182e6985-6640-487e-9381-07c5f86d5b46Test

الإتاحة: http://www.hbo-kennisbank.nl/en/page/hborecord.view/?uploadId=sharekit_zuyd:oai:surfsharekit.nl:5f1c0f89-f5d1-4d47-bbe1-13b117f453edTest

المؤلفون: Laura Ramos, Jeny Teo-Loy, Manuel Barreiro-de Acosta

المصدر: Frontiers in Medicine, Vol 9 (2023)

مصطلحات موضوعية: ulcerative colitis, disease clearance, therapeutic goals, outcomes, remission, Medicine (General), R5-920

وصف الملف: electronic resource

العلاقة: https://www.frontiersin.org/articles/10.3389/fmed.2022.1102420/fullTest; https://doaj.org/toc/2296-858XTest

الوصول الحر: https://doaj.org/article/ba070f1cc0b24a62a4a4c87122219cbfTest

المؤلفون: Vita, Antonio, Fagiolini, Andrea, Maina, Giuseppe, Mencacci, Claudio, Spina, Edoardo, Galderisi, Silvana

المساهمون: Vita, Antonio, Fagiolini, Andrea, Maina, Giuseppe, Mencacci, Claudio, Spina, Edoardo, Galderisi, Silvana

مصطلحات موضوعية: Long-acting injectable, Risperidone ISM®, Schizophrenia, Therapeutic goals

وصف الملف: ELETTRONICO

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/36650545; info:eu-repo/semantics/altIdentifier/wos/WOS:000917139000001; volume:22; issue:1; journal:ANNALS OF GENERAL PSYCHIATRY; https://hdl.handle.net/11365/1225729Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85146353249; https://annals-general-psychiatry.biomedcentral.com/articles/10.1186/s12991-022-00430-1Test

الإتاحة: https://doi.org/10.1186/s12991-022-00430-1Test
https://hdl.handle.net/11365/1225729Test

المؤلفون: Damian M. May, Jeffrey L. Neul, Ambika Satija, Wendy Y. Cheng, Neema Lema, Andra Boca, Patrick Lefebvre, Jesús Eric Piña-Garza

مصطلحات موضوعية: Medicine, Neuroscience, Biotechnology, Sociology, Cancer, Statistics, Science Policy, Hematology, Environmental Sciences not elsewhere classified, Rett syndrome, physician survey, diagnosis, clinical management, therapeutic goals, I14, I1, I12

العلاقة: https://figshare.com/articles/journal_contribution/Real-world_clinical_management_of_individuals_with_Rett_syndrome_a_physician_survey/24625320Test

الإتاحة: https://doi.org/10.6084/m9.figshare.24625320.v1Test
https://figshare.com/articles/journal_contribution/Real-world_clinical_management_of_individuals_with_Rett_syndrome_a_physician_survey/24625320Test

المؤلفون: Ofra Kriger-Sharabi, Uri Kopylov

المصدر: Journal of Clinical Medicine; Volume 12; Issue 7; Pages: 2696

مصطلحات موضوعية: Crohn’s disease, Inflammatory Bowel Diseases, biomarkers, precision medicine, patient stratification, microbiome, GWAS, multi-omics, therapeutic goals

وصف الملف: application/pdf

العلاقة: Gastroenterology & Hepatopancreatobiliary Medicine; https://dx.doi.org/10.3390/jcm12072696Test

الإتاحة: https://doi.org/10.3390/jcm12072696Test

المؤلفون: Goyeneche, Helber, Ardila, Rubiela, Villamil, Patricia, Moncayo, Andrés Francisco

المصدر: https://revistas.fucsalud.edu.co/index.php/repertorio/article/view/857Test.

مصطلحات موضوعية: síndrome metabólico, metas terapéuticas, riesgo cardiovascular, metabolic syndrome, therapeutic goals, cardiovascular risk

وصف الملف: application/pdf

العلاقة: Cornier MA, Dabelea D, Hernandez TL, Lindstrom RC, Steig AJ, Stob NR, et al. The metabolic syndrome. Endocr Rev. 2008 Dec:29(7):777-822. 2. Eckel RH, Grundy SM, ZimmetPZ. The metabolic syndrome. Lancet. 2005 Apr l 6;365(9468):1415-28. 3. Mottillo S,Filion KB, Genest J, Joseph L, Pilote L, Poirier P, et al. The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J Am Coll Cardiol. 2010 Sep 28;56(14):1113-32. 4. Organización Panamericana de la Salud. CARMEN Una Iniciativa para Conjunto de Acciones para la Reducción Multifactorial de Enfermedades No transmisibles [monografía en Internet]. Habana, Cuba: OPS; 2002 [citado 12Feb.2013]. Dispo­ nible en: http://www.paho.org/spanish/ad/dpc/nc/CARMEN-doc2.pdfTest 5. National Cholesterol Education Program (NCEP) Expert Panel on Detec­ tion, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult­ Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation. and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel Ill) final report. Circulation. 2002 Dec l7;106(25):3143-42I. 6. Ervin RB. Prevalence of metabolic syndrome among adults 20 years of age and over, by sex, age, race and ethnicity, and body mass index: United States, 2003- 2006. Natl Health Stat Report. 2009 May 5;(13):1-7. 7. Villegas A, Botero J, Arango !, Arias S, Toro M. Prevalencia del síndrome meta­ bólico en El Retiro, Colombia. Iatreia. 2010;16(4):291-7. 8. Manzur F, Alvear C, Alayón A. Caracterización fenotípica y metabólica del síndrome metabólico en Cartagena de Indias. Rev Colomb Cardiol. 2008;15(3): 99-101. 9. Navarro E, Vargas R. Síndrome metabólico en el suroccidente de Barranquilla (Colombia). Salud Uninorte. 2008;24(1):40-52. 10. Pinzón J.B. Impacto de las nuevas definiciones en la prevalencia del síndrome metabólico en una población adulta de Bucaramanga, Colombia. Biomedica. 2007;27(172):179. 11. Manzur F, De la Ossa M, Trespalacios E, Abuabara T, Lujan M. Prevalencia de síndrome metabólico en el municipio de Arjona,Colombia. Rev. Colomb. Car­ diol. 2008 Sep;l 5(5):215-22. 12. Lombo B, Villalobos C, Tique C, Satizábal C, Franco C. Prevalencia del sín­ drome metabólico entre los pacientes que asisten al servicio Clínica de Hiper­ tensión de laFundación SantaFe de Bogotá. Rev. Colomb. Cardiol. 2006 May; 12(7):472-8. 13. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood lnstitute Scientific Statement. Exe­ cutive summary. Cardiol Rev. 2005 Nov;l3(6):322-7. 14. Athyros VG, Mikhailidis DP, Papageorgiou M, Didangelos TP, Peletidou A, Kleta D, et al. Targeting vascular risk in patients with metabolic syndrome but without diabetes. Metabolism. 2005 Aug; 54(8):1065-74. 15. Alvarez M, Suarez C, Mantilla T, Franch J, Ruilope L, Banejas J. Estudio PRE­ VENCAT: control del riesgo cardiovascular en atención primaria. Med Clin (Barc). 2005;124(11):406-10. 16. Alberti KG, Zimmet P, Shaw J. Metabolic syndrome -a new world- wide defini­ tion. A Consensus Statement from the International Diabetes Federation. Diabet Med. 2006 May;23(5J:469-80. 17. ldg.org [página en Internet]. Brussels, Belgium: lnternational Diabetes Federa­ tion; 2010 [citado Nov. 2010]. Disponible en: http://www.idforgTest 18. Arias L, Montero J, Catellanos J. lnteración humana integralidad y ciclos vitales: el ciclo vital individual. Bogotá: Ministerio de Salud; 1993. 19. Friedewald WT, Levy Rl, Fredrickson OS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ul­ tracentrifuge. Clin Chem. 1972 Jun;18(6):499-502. 20. EUROASPIRE. A European Society of Cardiology survey of secondary preven­ tion of coronary heart disease: principal results. EUROASPIRE Study Group. European Action on Secondary Prevention through Intervention to Reduce Events. Eur Heart J. 1997 Oct;18(10):1569-82. 21. Gaede P, Vede! P, Larsen N, Jensen GV, Parving HH, Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med. 2003 Jan 30;348(5):383-93. 22. Barrios V, Escobar C, Calderon A, Llisterri JL, Alegria E, Muniz J, et al. Preva­ lence of the metabolic syndrome in patients with hypertension treated in general practice in Spain: an assessment of blood pressure and low-density lipoprotein cholesterol control and accuracy of diagnosis. J Cardiometab Syndr. 2007;2(1):9- 15. 23. Llisterri Caro JL, Rodríguez Roca GC, Alonso MorenoFJ, Lou AS, Divisan Ga­ rrote JA, Santos Rodríguez JA, et al. [Blood pressure control in Spanish hyper­ tensive patients in Primary Health Care Centres. PRESCAP 2002 Study]. Med Clin (Barc). 2004Feb 14;122(5):165-71. 24. Alonso M, Llisterri J, Rodrlguez G, Ferreiro M, Gonziilez D, División J, et al. Conducta del médico de Atención Primaria ante el mal control de los pacientes hipertensos. Estudio PRESCAP 2006. Rev Clin Esp. 2008;208(8):393-9. 25. Downs JR, Clearfield M, Weis S, Whitney E, Shapiro DR, Beere PA, et al. Pri­ mary prevention of acute coronary events with lovastatin in men and women with averagecholesterollevels: results of AFCAPS/TexCAPS. AirForce/Texas Coro­ nary Atherosclerosis Prevention Study. JAMA. 1998 May 27;279(20):1615-22. 26. Pascual JM, Rodilla E, Costa JA, Perez-Lahiguera F, Gonzalez C, Lurbe E, et al. Body weight variation and control of cardiovascular risk factors in essential hypertension. Blood Press. 2009;18(5):247-54. 27. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002Feb 7;346(6):393-403. 28. Roussel R, TravertF, Pasquet B, Wilson PW, Smith SC, Jr., Goto S, et al. Metfor­ min use and mortality among patients with diabetes and atherothrombosis. Arch lntern Med. 2010 Nov 22;170(21):1892-9.; https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/857/889Test; Núm. 2 , Año 2013 : Abril – Junio; 107; 98; 22; Revista Repertorio de Medicina y Cirugía; https://repositorio.fucsalud.edu.co/handle/001/2875Test; https://doi.org/10.31260/RepertMedCir.v22.n2.2013.857Test

الإتاحة: https://doi.org/10.31260/RepertMedCir.v22.n2.2013.857Test
https://repositorio.fucsalud.edu.co/handle/001/2875Test

المؤلفون: Rubén Queiro-Silva, Andrea García-Valle, Sara Alonso-Castro, Mercedes Alperi-López

المصدر: Frontiers in Medicine, Vol 8 (2021)

مصطلحات موضوعية: axial spondyloarthritis, NSAIDs, therapeutic goals, gut dysbiosis, long-term prognosis, disease activity, Medicine (General), R5-920

وصف الملف: electronic resource

العلاقة: https://www.frontiersin.org/articles/10.3389/fmed.2021.817884/fullTest; https://doaj.org/toc/2296-858XTest

الوصول الحر: https://doaj.org/article/5408b6814ac841fbb04c6d9f0d45943eTest